Medications

New cell-based immunotherapy offered for melanoma

Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, is one of the first centers nationwide to offer a newly approved cell-based immunotherapy that targets melanoma.

Diseases, Conditions, Syndromes

Study: 'Hexaplex' vaccine aims to boost flu protection

Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines. They're easy to produce precisely. They're safe and potentially more effective. And they ...

Diseases, Conditions, Syndromes

Study shows glucagon is key for kidney health

Glucagon, a hormone best known for promoting blood sugar production in the liver, also appears to play a key role in maintaining kidney health. When UT Southwestern Medical Center researchers removed receptors for this hormone ...

Oncology & Cancer

Immune cell receptor provides promising immunotherapy target

Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients' immune systems fight back against cancer, according to a study by investigators at the ...

Medical research

Closing the clinical trials disparity gap

Getting sufficient representation of racial and ethnic minority populations in clinical trials remains a pervasive challenge, despite concerted efforts by researchers and mandates set by funding sources and regulatory agencies. ...

page 11 from 40